Walking while Talking in Older Adults with Chronic Kidney Disease

被引:9
|
作者
Ho, Jim Q. [1 ]
Verghese, Joe [1 ,2 ,3 ]
Abramowitz, Matthew K. [1 ,3 ,4 ,5 ]
机构
[1] Albert Einstein Coll Med, Dept Med, Bronx, NY 10461 USA
[2] Albert Einstein Coll Med, Dept Neurol, Bronx, NY 10461 USA
[3] Albert Einstein Coll Med, Inst Aging Res, Bronx, NY 10461 USA
[4] Albert Einstein Coll Med, Diabet Res Ctr, Bronx, NY 10461 USA
[5] Albert Einstein Coll Med, Fleischer Inst Diabet & Metab, Bronx, NY 10461 USA
基金
美国国家卫生研究院;
关键词
geriatric nephrology; Aged; Walking Speed; Walking; Accidental Falls; Independent Living; Frailty; Gait Analysis; Factor Analysis; Statistical; glomerular filtration rate; Gait; Cognitive Dysfunction; Linear Models; EGFR protein; human; ErbB Receptors; Renal Insufficiency; Chronic; Cognition; MILD COGNITIVE IMPAIRMENT; GAITRITE(R) WALKWAY SYSTEM; MOTOR INTERFERENCE; GAIT VARIABILITY; DUAL-TASKING; FALL RISK; ATTENTION; PERFORMANCE; PREVALENCE; PARAMETERS;
D O I
10.2215/CJN.12401019
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Background and objectives Walking while talking is a dual cognitive-motor task that predicts frailty, falls, and cognitive decline in the general elderly population. Adults with CKD have gait abnormalities during usual walking. It is unknown whether they have greater gait abnormalities and cognitive-motor interference during walking while talking. Design, setting, participants,& measurementsCommunity-dwelling, nondisabledadults (n=330)>65 years of age underwent quantitative gait analysis, including walking while talking. Differences in walking-while-talking performance by CKD status were evaluated, and relative changes between walking-while-talking and walking alone performance were computed to quantify cognitive-motor interference (dual-task cost). Associations were tested using multivariable linear spline regression models, and independent gait domains were derived using factor analysis. CKD was defined as an eGFR<60 ml/min per 1.73 m(2). Results CKD was present in 134 (41%) participants. Participants with CKD had slower gait speed along with various gait cycle abnormalities during walking while talking: among those with CKD, every 10-ml/min per 1.73 m2 lower eGFR was associated with 3.3-cm/s (95% confidence interval, 0.4 to 6.1) slower gait speed, 1.8-cm (95% confidence interval, 0.6 to 3.0) shorter step length, 1.1% (95% confidence interval, 0.6 to 1.7) less time in the swing phase, and 1.4% (95% confidence interval, 0.5 to 2.3) greater time in double support after multivariable adjustment. When comparing walking while talking with walking alone, every 10-ml/min per 1.73 m(2) lower eGFR was associated with 1.8%(95% confidence interval, 0.5 to 3.2) greater decrease in time in the swing phase and 0.9% (95% confidence interval, 0.2 to 1.5) greater increase in time in the stance phase. Factor analysis identified three walking-while-talking domains and three dual-task cost domains: eGFR was associated specifically with the rhythm domain for both walking-while-talking and dual-task cost. Every 10-ml/min per 1.73 m(2) lower eGFR was associated with a poorer performance of 0.2 SD (95% confidence interval, 0.1 to 0.3) for walking while talking and 0.2 SD (95% confidence interval, 0.03 to 0.3) for dual-task cost. Conclusions During walking while talking, CKD is associated with gait abnormalities, possibly due to increased cognitive-motor interference.
引用
收藏
页码:665 / 672
页数:8
相关论文
共 50 条
  • [21] 'Faster counting while walking' as a predictor of falls in older adults
    Beauchet, Olivier
    Dubost, Veronique
    Allai, Gilles
    Gonthier, Regis
    Hermann, Francois R.
    Kressig, Reto W.
    AGE AND AGEING, 2007, 36 (04) : 418 - 423
  • [22] The Effects of Cognition and Vision While Walking in Younger and Older Adults
    Pham, Trong
    Suen, Meagan
    Cho, Young-Hee
    Krishnan, Vennila
    SENSORS, 2024, 24 (23)
  • [23] Chronic kidney disease and orthostatic hypotension in hospitalised older adults
    Curcio, Francesco
    Chiappetti, Rosaria
    De Furio, Mattia
    Flocco, Veronica
    Della Morte, David
    Testa, Gianluca
    Gargiulo, Gaetano
    Cacciatore, Francesco
    Abete, Pasquale
    Galizia, Gianluigi
    BLOOD PRESSURE, 2024, 33 (01)
  • [24] Treatment decisions for older adults with advanced chronic kidney disease
    Rosansky, Steven J.
    Schell, Jane
    Shega, Joseph
    Scherer, Jennifer
    Jacobs, Laurie
    Couchoud, Cecile
    Crews, Deidra
    McNabney, Matthew
    BMC NEPHROLOGY, 2017, 18
  • [25] Protein Intake and Mortality in Older Adults With Chronic Kidney Disease
    Carballo-Casla, Adrian
    Avesani, Carla Maria
    Beridze, Giorgi
    Ortola, Rosario
    Garcia-Esquinas, Esther
    Lopez-Garcia, Esther
    Dai, Lu
    Dunk, Michelle M.
    Stenvinkel, Peter
    Lindholm, Bengt
    Carrero, Juan Jesus
    Rodriguez-Artalejo, Fernando
    Vetrano, Davide Liborio
    Calderon-Larranaga, Amaia
    JAMA NETWORK OPEN, 2024, 7 (08)
  • [26] Prevalence and factors associated to chronic kidney disease in older adults
    Maciel Amaral, Thatiana Lameira
    Amaral, Cledir de Araujo
    Leite de Vasconcellos, Mauricio Teixeira
    Rego Monteiro, Gina Torres
    REVISTA DE SAUDE PUBLICA, 2019, 53
  • [27] CHRONIC KIDNEY DISEASE AND OLDER ADULTS: A REVIEW OF THE AGING LITERATURE
    Washington, T. R.
    Hilliard, T.
    GERONTOLOGIST, 2012, 52 : 638 - 639
  • [28] Managing chronic kidney disease in the older adults living with HIV
    Post, Frank A.
    CURRENT OPINION IN INFECTIOUS DISEASES, 2017, 30 (01) : 4 - 11
  • [29] Opioid Management in Older Adults with Chronic Kidney Disease: A Review
    Owsiany, Montgomery T.
    Hawley, Chelsea E.
    Triantafylidis, Laura K.
    Paik, Julie M.
    AMERICAN JOURNAL OF MEDICINE, 2019, 132 (12): : 1386 - 1393
  • [30] Prevention of Chronic Kidney Disease and Its Complications in Older Adults
    Tungsanga, Somkanya
    Bello, Aminu K.
    DRUGS & AGING, 2024, 41 (07) : 565 - 576